澳大利亚肺炎球菌疾病高风险成人肺炎球菌疫苗接种的预测因素
该研究分析2019年8月至2020年9月澳大利亚三项在线横断面调查数据,用泊松回归识别65岁及以上或患慢性病成人自报肺炎球菌疫苗接种的相关特征与信念。加权估计显示,65岁以下高风险成人接种覆盖率为24%,65岁及以上为53%。
要点
- 65岁以下高风险成人中近半数从未听说过肺炎球菌疫苗,65岁及以上为26%。
- 65岁以下者接种与医生推荐(PR=3.02)、知晓慢性病增加肺炎风险(PR=2.44)相关。
- 65岁及以上者接种与过去12个月接种流感疫苗(PR=4.28)、知晓可免费接种(PR=5.02)相关。
核心结论
- 肺炎球菌疾病高风险成人对肺炎球菌疫苗的认知较低,似乎导致了疫苗接种率低。
- 医生推荐与肺炎球菌疫苗接种率升高相关,因此应制定干预措施在全科诊所促进肺炎球菌疫苗接种。
研究设计与样本
- 本文报告了2019年8月至2020年9月在澳大利亚开展的三项不同在线横断面调查中收集的肺炎球菌疫苗接种合并数据。
- 使用泊松回归识别65岁及以上或患有慢性健康问题的成人中与自报肺炎球菌疫苗接种相关的特征和信念。
主要发现
- 加权估计的肺炎球菌疫苗覆盖率:65岁以下高风险成人为24%,65岁及以上成人为53%。
- 65岁以下者中,近半数报告从未听说过肺炎球菌疫苗;65岁及以上者中26%从未听说过该疫苗。
- 65岁以下者中,肺炎球菌疫苗接种与高感知疾病易感性(PR=1.97,95%CI:1.23,3.18)相关。
- 65岁以下者中,未听说过肺炎球菌疫苗与接种相关(PR=0.44,95%CI:0.28-0.69)。
- 65岁以下者中,知晓其慢性健康问题增加肺炎风险(PR=2.44,95%CI:1.51-3.98)及医生推荐疫苗(PR=3.02,95%CI:2.05-4.44)与接种相关。
临床怎么用
- 作者建议应制定干预措施在全科诊所促进肺炎球菌疫苗接种。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although nearly all Australian children are vaccinated against pneumococcal disease, pneumococcal vaccine uptake is low among high-risk adults. This study aimed to identify perceived barriers to pneumococcal vaccination among high-risk adults. METHODS: This paper reports combined data on pneumococcal vaccination collected from three different online, cross-sectional surveys that were administered in Australia between August 2019 and September 2020. Using Poisson regression, we identified characteristics and beliefs associated with self-reported pneumococcal vaccination among adults aged 65 and over or with chronic health conditions. RESULTS: The weighted estimate for pneumococcal vaccine coverage was 24% for high-risk adults under 65 and 53% for adults aged 65 and over. Nearly half of those under 65 reported they had never heard of the pneumococcal vaccine, while 26% of those aged 65 and over had never heard of the vaccine. Among those under 65, pneumococcal vaccination was associated with high perceived disease susceptibility (PR = 1.97, 95% CI: 1.23, 3.18), not having heard of the pneumococcal vaccine (PR = 0.44, 95% CI: 0.28-0.69), awareness that their chronic health condition puts them at increased risk of pneumonia (PR = 2.44, 95% CI: 1.51-3.98), and having a doctor recommend the vaccine (PR = 3.02, 95% CI: 2.05-4.44). Among adults aged 65 and over, self-reported pneumococcal vaccination was associated with influenza vaccination in the previous 12 months (PR = 4.28, 95% CI: 2.85-6.44) and awareness that they are eligible for free pneumococcal vaccination (PR = 5.02, 95% CI: 2.34-10.77). CONCLUSION: Awareness of pneumococcal vaccines was low among adults at high risk of pneumococcal disease, which appears to be contributing to low vaccine uptake. A doctor's recommendation was associated with increased uptake of pneumococcal vaccine, so interventions should be developed to promote pneumococcal vaccine uptake in GP practices.
引用
- Trent MJ, Salmon DA, MacIntyre CR, et al. Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease. Vaccine. 2022. PMID: 35078659. doi:10.1016/j.vaccine.2022.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。